severe abdominal pain bleeding
Posted by admin on 30 May, 2011
No comments yet
This item was filled under [ Most Popular ]
Onyx Pharmaceuticals Announces Updated Pivotal Carfilzomib Phase 2B Data
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) announced updated results from the Phase 2b 003-A1 study of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and refractory multiple myeloma. Carfilzomib achieved a clinical benefit rate (CBR) (minimal response or greater) in the study population of 37 percent with a duration of response (DOR) of 8.3 months. The …
may27 2010, rodel colonoscopy 030.mpg
